INVITATION
GSK - Update on the evolving landscape for endometrial cancer treatment with Immunotherapy
INVITATION
AstraZeneca - Redefining long-term outcomes in the era of personalised medicine: Maintenance treatment in newly diagnosed ovarian cancer
INVITATION
GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence